The present invention is directed to selective LXR modulators, small molecule compounds corresponding to Formula I and is further directed to a process of treating a condition in a mammal that is modulated by LXR using a therapeutically effective dose of a compound of Formula I.
本发明涉及选择性 LXR 调节剂、对应于式 I 的
小分子化合物,并进一步涉及使用治疗有效剂量的式 I 化合物治疗哺乳动物体内受 LXR 调节的病症的过程。